Avance Clinical CEO Yvonne Lungershausen on a visit to New Zealand sites: At New Zealand Clinical Research (NZCR): Christian Schwabe, Yvonne Lungershausen, Angie Edwards (Avance Clinical SPM), and Mary Ellis-Pegler.
Avance Clinical CEO Yvonne Lungershausen on a visit to New Zealand sites: At New Zealand Clinical Research (NZCR): Christian Schwabe, Yvonne Lungershausen, Angie Edwards (Avance Clinical SPM), and Mary Ellis-Pegler.
At Optimal Clinical Trials: Angie Edwards (Avance Clinical SPM), Yvonne Lungershausen, Dr Liz Smaill, and Dr Barney Montgomery
Avance Clinical works closely with the leading sites in New Zealand as part of its regional CRO offering to international biotechs.
New Zealand has a global reputation for high-calibre site teams, PIs and KOLs, and medical and clinical research expertise, and a long track record conducting quality clinical trials for biotech companies.
Globally accepted data
Like Australia, data generated in New Zealand is readily accepted by the main regulatory authorities, including the FDA and EMA.
Relationships are an important part of delivering streamlined CRO services across regions.
Avance Clinical is committed to regular communications and visits to sites in New Zealand to support the conduct of Avance Clinical trials.
Seamless technology
Technology plays a significant role in managing trials across Australia and New Zealand which is why sites in the Avance Clinical network use the latest tools from Medrio, Medidata, and Oracle to collaborate in real-time with the Avance Clinical data team.
New Zealand advantages
New Zealand offers significant advantages across many indications including seasonal conditions, metabolic disorders, and allergies, and the diverse ethnic population is also attractive for biotechs conducting early to late phase studies.
The streamlined regulatory process is also attractive for biotechs wanting rapid start-up and approvals.
Avance Clinical works with the leading sites including NZCTR, Optimal Clinical Trials, and P3 Research.
“Within Asia-Pacific’s highly competitive CRO market, Avance Clinical stands out as a leader in early phase biotech clinical trials.
The company offers a highly responsive and proactive service for biotechs wanting rapid and innovative clinical trial solutions, with the highest level of data compliance. Avance Clinical offers a real size match for biotechs that means better mission understandings and stronger customer service compared to some of the larger CROs.”
Nidhi JalaliAnalyst Best Practices, Frost & Sullivan